What Does NeuroPace Do?

Total employees222
HeadquartersMountain View
Founded1999

NeuroPace is a commercial-stage medical device company dedicated to transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of disabling seizures. Their flagship product, the RNS® System, is the first and only FDA-approved brain-responsive neurostimulation system that delivers personalized, real-time treatment at the seizure source. By monitoring brain activity and responding with imperceptible stimulation, the RNS System offers a new level of control for patients with refractory epilepsy who have not responded to medication. NeuroPace is committed to advancing the understanding and treatment of neurological disorders through continuous innovation and data-driven insights derived from its extensive brain data platform.

Where Is NeuroPace's Headquarters?

HQ Function

Serves as the primary center for NeuroPace's corporate leadership, research and development, manufacturing, clinical operations, sales, and marketing efforts.

Notable Features:

Modern facility likely equipped with state-of-the-art laboratories for medical device development, cleanroom environments for manufacturing, and collaborative office spaces designed to foster innovation.

Work Culture:

A dynamic and mission-driven work environment focused on innovation in neurotechnology, scientific rigor, and a strong commitment to improving patient outcomes. The culture likely encourages collaboration, continuous learning, and a fast-paced approach typical of Silicon Valley med-tech companies.

HQ Significance:

Its Silicon Valley location provides access to a rich ecosystem of technological talent, research institutions, venture capital, and other medical technology companies, fostering innovation and partnerships.

Values Reflected in HQ: The headquarters likely reflects NeuroPace's core values of innovation, patient-centricity, scientific excellence, and collaboration through its functional design, investment in technology, and environment that supports its highly skilled workforce.

Location:

NeuroPace's RNS System is currently FDA-approved and primarily marketed within the United States. The company focuses its commercial operations and direct patient treatment solutions on the U.S. market. While NeuroPace engages with the global neurology community through research, publications, and participation in international conferences, its direct sales and support infrastructure is concentrated in the U.S. Future international expansion would depend on obtaining regulatory approvals in other countries and regions.

Street Address:

455 N. Bernardo Ave

City:

Mountain View

State/Province:

CA

Country:

USA

Where Else Does NeuroPace Operate Around the World?

No additional office locations available.

Buying Intent Signals for NeuroPace

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading NeuroPace? Meet the Executive Team

As of April 2025, NeuroPace' leadership includes:

Joel Becker - President and Chief Executive Officer
Rebecca Kuhn - Chief Financial Officer
Michael D. Favet, PhD - Chief Clinical & Technical Officer
Corey Schiller - Chief Commercial Officer
David M. Van Sickle, PhD - Chief Technology Officer

Who's Investing in NeuroPace?

NeuroPace has been backed by several prominent investors over the years, including:

KKR & Co. Inc.
OrbiMed Advisors LLC
New Enterprise Associates (NEA)
Johnson & Johnson Innovation - JJDC
Accelmed Partners
RTW Investments, LP
The Vanguard Group, Inc.
BlackRock Inc.

What Leadership Changes Has NeuroPace Seen Recently?

Hire3
Exits0

Over the past 12-18 months, NeuroPace has strengthened its leadership team with key appointments and promotions, including a new Chief Commercial Officer and promotions to Chief Clinical & Technical Officer and Chief Technology Officer, underscoring its commitment to commercial growth and technological innovation. No prominent C-suite departures were publicly announced during this period.

New Appointments:

Corey Schiller, Corey Schiller appointed as Chief Commercial Officer to drive NeuroPace's commercial growth and market strategy.
Michael D. Favet, PhD, Michael D. Favet, PhD, was promoted to Chief Clinical & Technical Officer, expanding his leadership over clinical affairs and technical product development.
David M. Van Sickle, PhD, David M. Van Sickle, PhD, was promoted to Chief Technology Officer, responsible for guiding the company's technology roadmap and innovation pipeline.

What Technology (Tech Stack) Is Used byNeuroPace?

Discover the tools NeuroPace uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

NeuroPace Email Formats and Examples

NeuroPace likely utilizes common corporate email address formats. The most probable patterns combine an employee's first initial and last name, or their full first name and last name separated by a dot.

[first_initial][last]@neuropace.com or [first].[last]@neuropace.com

Format

jdoe@neuropace.com

Example

80%

Success rate

What's the Latest News About NeuroPace?

GlobeNewswireMay 8, 2024

NeuroPace Reports First Quarter 2024 Financial Results and Reiterates Full-Year 2024 Guidance

NeuroPace announced total revenue of $15.3 million for Q1 2024, a 29% increase year-over-year. The company reiterated its full-year 2024 revenue guidance of $70 million to $75 million....more

GlobeNewswireApril 25, 2024

NeuroPace to Announce First Quarter 2024 Financial Results on May 8, 2024

NeuroPace, Inc. (Nasdaq: NPCE) announced that it would report financial results for the first quarter of 2024 after market close on Wednesday, May 8, 2024, followed by a conference call....more

GlobeNewswireMarch 5, 2024

NeuroPace Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Guidance

NeuroPace reported record total revenue of $17.0 million for the fourth quarter of 2023, representing a 40% increase over the prior year period. Full year 2023 total revenue was $60.6 million, a 34% increase....more

GlobeNewswireFebruary 20, 2024

NeuroPace Announces Publication of Real-World Data Demonstrating Significant and Sustained Reduction in Seizure Frequency with the RNS System

NeuroPace announced the publication of new data from its real-world patient registry in the journal Epilepsia, showing continued significant and sustained reduction in seizure frequency in patients treated with the RNS System. The study included over 2,000 patients and reported a median 82% reduction in disabling seizures at 3+ years post-implant....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including NeuroPace, are just a search away.